vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and Riley Exploration Permian, Inc. (REPX). Click either name above to swap in a different company.

Riley Exploration Permian, Inc. is the larger business by last-quarter revenue ($97.3M vs $71.1M, roughly 1.4× Fulgent Genetics, Inc.). On growth, Fulgent Genetics, Inc. posted the faster year-over-year revenue change (-3.2% vs -5.3%). Over the past eight quarters, Fulgent Genetics, Inc.'s revenue compounded faster (0.1% CAGR vs -1.2%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

Riley Exploration Permian, Inc. is an independent energy company focused on exploration, development, and production of crude oil, natural gas, and natural gas liquids primarily in the US Permian Basin spanning Texas and New Mexico. It prioritizes cost-efficient onshore reserve development to supply reliable energy products to North American markets.

FLGT vs REPX — Head-to-Head

Bigger by revenue
REPX
REPX
1.4× larger
REPX
$97.3M
$71.1M
FLGT
Growing faster (revenue YoY)
FLGT
FLGT
+2.1% gap
FLGT
-3.2%
-5.3%
REPX
Faster 2-yr revenue CAGR
FLGT
FLGT
Annualised
FLGT
0.1%
-1.2%
REPX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FLGT
FLGT
REPX
REPX
Revenue
$71.1M
$97.3M
Net Profit
Gross Margin
30.2%
Operating Margin
21.1%
26.9%
Net Margin
Revenue YoY
-3.2%
-5.3%
Net Profit YoY
EPS (diluted)
$0.04
$4.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
REPX
REPX
Q1 26
$71.1M
Q4 25
$83.3M
$97.3M
Q3 25
$84.1M
$106.9M
Q2 25
$81.8M
$85.4M
Q1 25
$73.5M
$102.5M
Q4 24
$76.2M
$102.7M
Q3 24
$71.7M
$102.3M
Q2 24
$71.0M
$105.4M
Net Profit
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
$-23.4M
Q3 25
$-6.6M
$16.3M
Q2 25
$-19.0M
$30.5M
Q1 25
$-11.5M
$28.6M
Q4 24
$-5.9M
Q3 24
$-14.6M
$25.7M
Q2 24
$-8.7M
$33.5M
Gross Margin
FLGT
FLGT
REPX
REPX
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
REPX
REPX
Q1 26
21.1%
Q4 25
-43.5%
26.9%
Q3 25
-18.3%
27.0%
Q2 25
-24.1%
33.7%
Q1 25
-26.9%
48.3%
Q4 24
-21.2%
31.2%
Q3 24
-23.8%
17.1%
Q2 24
-26.6%
50.9%
Net Margin
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
-28.1%
Q3 25
-7.9%
15.3%
Q2 25
-23.2%
35.7%
Q1 25
-15.7%
27.9%
Q4 24
-7.7%
Q3 24
-20.4%
25.1%
Q2 24
-12.3%
31.8%
EPS (diluted)
FLGT
FLGT
REPX
REPX
Q1 26
$0.04
Q4 25
$4.02
Q3 25
$0.77
Q2 25
$1.44
Q1 25
$1.36
Q4 24
$0.52
Q3 24
$1.21
Q2 24
$1.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
REPX
REPX
Cash + ST InvestmentsLiquidity on hand
$23.4M
Total DebtLower is stronger
$247.9M
Stockholders' EquityBook value
$634.2M
Total Assets
$1.2B
$1.2B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
REPX
REPX
Q1 26
$23.4M
Q4 25
$50.2M
Q3 25
$117.6M
Q2 25
$87.9M
Q1 25
$67.3M
Q4 24
$55.1M
Q3 24
$58.0M
Q2 24
$65.1M
Total Debt
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
$247.9M
Q3 25
$367.0M
Q2 25
$275.2M
Q1 25
$249.3M
Q4 24
$269.5M
Q3 24
$288.6M
Q2 24
$322.7M
Stockholders' Equity
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
$1.1B
$634.2M
Q3 25
$1.1B
$566.5M
Q2 25
$1.1B
$556.9M
Q1 25
$1.1B
$532.4M
Q4 24
$1.1B
$510.6M
Q3 24
$1.1B
$507.4M
Q2 24
$1.1B
$489.0M
Total Assets
FLGT
FLGT
REPX
REPX
Q1 26
$1.2B
Q4 25
$1.2B
$1.2B
Q3 25
$1.2B
$1.2B
Q2 25
$1.2B
$1.0B
Q1 25
$1.2B
$994.9M
Q4 24
$1.2B
$993.5M
Q3 24
$1.2B
$997.9M
Q2 24
$1.2B
$1.0B
Debt / Equity
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
0.39×
Q3 25
0.65×
Q2 25
0.49×
Q1 25
0.47×
Q4 24
0.53×
Q3 24
0.57×
Q2 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLGT
FLGT
REPX
REPX
Operating Cash FlowLast quarter
$64.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
$-78.1M
$64.9M
Q3 25
$11.1M
$63.6M
Q2 25
$-30.2M
$33.6M
Q1 25
$-4.4M
$50.4M
Q4 24
$25.0M
$66.4M
Q3 24
$-15.5M
$72.1M
Q2 24
$4.3M
$51.6M
Free Cash Flow
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
$-83.1M
Q3 25
$5.1M
Q2 25
$-37.0M
Q1 25
$-9.1M
Q4 24
$21.2M
Q3 24
$-35.0M
Q2 24
$-8.7M
FCF Margin
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
-99.7%
Q3 25
6.0%
Q2 25
-45.2%
Q1 25
-12.5%
Q4 24
27.9%
Q3 24
-48.8%
Q2 24
-12.2%
Capex Intensity
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
6.0%
Q3 25
7.2%
Q2 25
8.3%
Q1 25
6.4%
Q4 24
5.0%
Q3 24
27.2%
Q2 24
18.2%
Cash Conversion
FLGT
FLGT
REPX
REPX
Q1 26
Q4 25
Q3 25
3.90×
Q2 25
1.10×
Q1 25
1.76×
Q4 24
Q3 24
2.81×
Q2 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons